MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q1 2015. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $212,000 | -22.9% | 6,939 | -5.5% | 0.02% | -15.8% |
| Q1 2016 | $275,000 | -41.6% | 7,339 | -32.7% | 0.02% | -50.0% |
| Q4 2015 | $471,000 | +0.9% | 10,904 | -12.4% | 0.04% | +2.7% |
| Q3 2015 | $467,000 | +10.4% | 12,450 | 0.0% | 0.04% | +27.6% |
| Q2 2015 | $423,000 | -2.8% | 12,450 | +1.3% | 0.03% | -3.3% |
| Q1 2015 | $435,000 | +2.6% | 12,294 | -1.3% | 0.03% | +3.4% |
| Q4 2014 | $424,000 | -11.7% | 12,450 | 0.0% | 0.03% | -17.1% |
| Q3 2014 | $480,000 | -23.2% | 12,450 | -22.4% | 0.04% | -16.7% |
| Q2 2014 | $625,000 | +13.8% | 16,050 | 0.0% | 0.04% | +20.0% |
| Q1 2014 | $549,000 | +37.2% | 16,050 | -15.9% | 0.04% | +29.6% |
| Q4 2013 | $400,000 | -1.0% | 19,080 | +11.1% | 0.03% | -22.9% |
| Q3 2013 | $404,000 | -15.1% | 17,180 | -3.1% | 0.04% | -28.6% |
| Q2 2013 | $476,000 | +7.4% | 17,730 | +1.7% | 0.05% | +4.3% |
| Q1 2013 | $443,000 | – | 17,440 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |